Kestra Medical Technologies, Ltd. (KMTS) Overview
- 1 May 2026: Period ending 31 Jul 2026; Estimate (m); Actual -0.75; Beat / miss (m).
- 1 Nov 2025: Period ending 31 Jan 2026; Estimate (m); Actual -0.61; Beat / miss (m).
- 1 Aug 2025: Period ending 31 Oct 2025; Estimate (m); Actual -0.64; Beat / miss (m).
- 1 May 2025: Period ending 31 Jul 2025; Estimate (m); Actual -0.50; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $28.80
- Previous close
- $28.46
- Change
- $0.34
- Change (%)
- 1.19%
- Close date
- 2026-11-06
- Previous close date
- 2026-09-29
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- KMTS
- +7.32%
- S&P 500
- (m)
1 year
- KMTS
- +21.57%
- S&P 500
- (m)
3 years
- KMTS
- (m)
- S&P 500
- (m)
5 years
- KMTS
- (m)
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
31 Jul 2026 ○ Estimate (m) ● Actual -0.75
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 May 2026 | 31 Jul 2026 | (m) | -0.75 | (m) | (m) |
| 1 Nov 2025 | 31 Jan 2026 | (m) | -0.61 | (m) | (m) |
| 1 Aug 2025 | 31 Oct 2025 | (m) | -0.64 | (m) | (m) |
| 1 May 2025 | 31 Jul 2025 | (m) | -0.50 | (m) | (m) |
| 1 Nov 2024 | 31 Jan 2025 | (m) | -1.25 | (m) | (m) |
30 Apr 2026 ○ Estimate (m) ● Actual -2.43
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 1 May 2025 | 30 Apr 2026 | (m) | -2.43 | (m) | (m) |
| 1 May 2024 | 30 Apr 2025 | (m) | -5.13 | (m) | (m) |
| 1 May 2023 | 30 Apr 2024 | (m) | -5.07 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
31 Jul 2026 ■ Revenue 30.97M ■ Earnings -44.09M — Profit margin -142.35%
30 Apr 2026 ■ Revenue 95.13M ■ Earnings -131.61M — Profit margin -138.36%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $28.80 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning KMTS
View more →(m)
Statistics
View more →Retained observations as of 2026-11-12; financial period ending 31 Jul 2026.
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- $-149.87M
- Operating margin · 12 months
- -134.48%
- Gross margin · 12 months
- 53.89%
- Profit margin
- -140.43%
- Return on assets · 12 month
- -48.85%
- Named executive and board stock awards · latest fiscal year
- (m)
- Index membership
- (m)
- Employees
- (m)
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 409.29K
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- 9.08%*
- Total return · month
- 11.00%*
- Total return · quarter
- 12.27%*
- Total return · half year
- 46.25%*
- Total return · year to date
- 7.32%*
- Total return · 1 year
- 21.57%*
- Total return · 3 years
- (m)
- Total return · 5 years
- (m)
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- Revenue · 12 month
- $106.73M
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Operating cash flow · 12 months
- $-87.72M
- Free cash flow · 12 months (USD)
- $-122.78M
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- (m)
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
Kestra Medical Technologies, Ltd. Overview
View more →(m)
(m)
- SEC CIK
- 1877184
- Industry (SIC)
- 3841 Surgical & Medical Instruments & Apparatus
- Country of operation
- United States
- Business address
- 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND, Washington, 98033, United States
- Fiscal year end
- 0430
- Phone
- (425) 279-8002
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |